Fractyl Health Appoints New CEO, Expands Board

Ticker: GUTS · Form: 8-K · Filed: Sep 3, 2025 · CIK: 1572616

Fractyl Health, Inc. 8-K Filing Summary
FieldDetail
CompanyFractyl Health, Inc. (GUTS)
Form Type8-K
Filed DateSep 3, 2025
Risk Levelmedium
Pages3
Reading Time3 min
Key Dollar Amounts$0.00001, $43,500, $10,000
Sentimentneutral

Sentiment: neutral

Topics: leadership-change, executive-appointment, board-of-directors

TL;DR

New CEO Paul Laikind takes over at Fractyl Health, board gets new members.

AI Summary

Fractyl Health, Inc. announced on August 29, 2025, a series of executive and board changes. Dr. Paul F. Laikind has been appointed as the new Chief Executive Officer, succeeding Dr. Barry G. Berman. Additionally, Dr. Laikind and Ms. Joanne E. Smith have been elected to the Board of Directors.

Why It Matters

This filing indicates a significant leadership transition at Fractyl Health, with a new CEO taking the helm and new directors joining the board, which could signal a shift in strategic direction.

Risk Assessment

Risk Level: medium — Leadership changes can introduce uncertainty and impact strategic execution, warranting a medium risk assessment.

Key Players & Entities

  • Fractyl Health, Inc. (company) — Registrant
  • Paul F. Laikind (person) — Newly appointed Chief Executive Officer and Director
  • Barry G. Berman (person) — Outgoing Chief Executive Officer
  • Joanne E. Smith (person) — Newly elected Director
  • August 29, 2025 (date) — Date of earliest event reported

FAQ

Who is the new CEO of Fractyl Health, Inc.?

Dr. Paul F. Laikind has been appointed as the new Chief Executive Officer.

Who did Dr. Paul F. Laikind succeed as CEO?

Dr. Paul F. Laikind succeeded Dr. Barry G. Berman as CEO.

When was the earliest event reported in this 8-K filing?

The earliest event reported was on August 29, 2025.

Who else was appointed to the Board of Directors?

Ms. Joanne E. Smith was also elected to the Board of Directors.

What is the state of incorporation for Fractyl Health, Inc.?

Fractyl Health, Inc. is incorporated in Delaware.

Filing Stats: 849 words · 3 min read · ~3 pages · Grade level 10.5 · Accepted 2025-09-03 07:05:28

Key Financial Figures

  • $0.00001 — nge on which registered Common Stock, $0.00001 par value per share GUTS The Nasdaq
  • $43,500 — ong other things, an annual retainer of $43,500 for each of Dr. Thompson's and Mr. Shef
  • $10,000 — eceive an additional annual retainer of $10,000 for such service. Each of Dr. Thompson

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Fractyl Health, Inc. Date: September 3, 2025 By: /s/ Harith Rajagopalan Harith Rajagopalan, M.D., Ph.D. Co-Founder, Chief Executive Officer and Director (Principal Executive Officer)

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.